BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33494416)

  • 21. Evaluation of the inverse electron demand Diels-Alder reaction in rats using a scandium-44-labelled tetrazine for pretargeted PET imaging.
    Edem PE; Sinnes JP; Pektor S; Bausbacher N; Rossin R; Yazdani A; Miederer M; Kjær A; Valliant JF; Robillard MS; Rösch F; Herth MM
    EJNMMI Res; 2019 May; 9(1):49. PubMed ID: 31140047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction.
    Membreno R; Cook BE; Zeglis BM
    J Vis Exp; 2019 Jan; (143):. PubMed ID: 30774125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy.
    Bryan JN; Jia F; Mohsin H; Sivaguru G; Anderson CJ; Miller WH; Henry CJ; Lewis MR
    Cancer Biol Ther; 2011 Jun; 11(12):1001-7. PubMed ID: 21464612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DOTA-tetrazine probes with modified linkers for tumor pretargeting.
    Läppchen T; Rossin R; van Mourik TR; Gruntz G; Hoeben FJM; Versteegen RM; Janssen HM; Lub J; Robillard MS
    Nucl Med Biol; 2017 Dec; 55():19-26. PubMed ID: 29028502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Structurally Diverse
    Adhikari K; Dewulf J; Vangestel C; Van der Veken P; Stroobants S; Elvas F; Augustyns K
    ACS Omega; 2023 Oct; 8(41):38252-38262. PubMed ID: 37867688
    [No Abstract]   [Full Text] [Related]  

  • 27. Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody.
    van Rij CM; Lütje S; Frielink C; Sharkey RM; Goldenberg DM; Franssen GM; McBride WJ; Rossi EA; Oyen WJ; Boerman OC
    Eur J Nucl Med Mol Imaging; 2013 Sep; 40(9):1377-83. PubMed ID: 23674207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.
    Bohrmann L; Poulie CBM; Rodríguez-Rodríguez C; Karagiozov S; Saatchi K; Herth MM; Häfeli UO
    PLoS One; 2024; 19(4):e0300466. PubMed ID: 38626058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue.
    Goos JACM; Davydova M; Dilling TR; Cho A; Cornejo MA; Gupta A; Price WS; Puttick S; Whittaker MR; Quinn JF; Davis TP; Lewis JS
    Nucl Med Biol; 2020; 84-85():63-72. PubMed ID: 32135473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of the First Aliphatic
    Battisti UM; Bratteby K; Jørgensen JT; Hvass L; Shalgunov V; Mikula H; Kjær A; Herth MM
    J Med Chem; 2021 Oct; 64(20):15297-15312. PubMed ID: 34649424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.
    Heskamp S; Hernandez R; Molkenboer-Kuenen JDM; Essler M; Bruchertseifer F; Morgenstern A; Steenbergen EJ; Cai W; Seidl C; McBride WJ; Goldenberg DM; Boerman OC
    J Nucl Med; 2017 Jun; 58(6):926-933. PubMed ID: 28232604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of [
    Otaru S; Paulus A; Imlimthan S; Kuurne I; Virtanen H; Liljenbäck H; Tolvanen T; Auchynnikava T; Roivainen A; Helariutta K; Sarparanta M; Airaksinen AJ
    Bioconjug Chem; 2022 Jul; 33(7):1393-1404. PubMed ID: 35709482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioorthogonal Masking of Circulating Antibody-TCO Groups Using Tetrazine-Functionalized Dextran Polymers.
    Meyer JP; Tully KM; Jackson J; Dilling TR; Reiner T; Lewis JS
    Bioconjug Chem; 2018 Feb; 29(2):538-545. PubMed ID: 29378403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha radioimmunotherapy using
    Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
    Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu.
    Mohsin H; Jia F; Bryan JN; Sivaguru G; Cutler CS; Ketring AR; Miller WH; Simón J; Frank RK; Theodore LJ; Axworthy DB; Jurisson SS; Lewis MR
    Bioconjug Chem; 2011 Dec; 22(12):2444-52. PubMed ID: 22053899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site-specific conjugation allows modulation of click reaction stoichiometry for pretargeted SPECT imaging.
    Mandikian D; Rafidi H; Adhikari P; Venkatraman P; Nazarova L; Fung G; Figueroa I; Ferl GZ; Ulufatu S; Ho J; McCaughey C; Lau J; Yu SF; Prabhu S; Sadowsky J; Boswell CA
    MAbs; 2018; 10(8):1269-1280. PubMed ID: 30199303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.
    Qiu L; Mao W; Yin H; Tan H; Cheng D; Shi H
    Contrast Media Mol Imaging; 2019; 2019():9182476. PubMed ID: 31531006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative immuno-SPECT monitoring of pretargeted radioimmunotherapy with a bispecific antibody in an intraperitoneal nude mouse model of human colon cancer.
    Schoffelen R; van der Graaf WT; Sharkey RM; Franssen GM; McBride WJ; Chang CH; Bos DL; Goldenberg DM; Oyen WJ; Boerman OC
    J Nucl Med; 2012 Dec; 53(12):1926-32. PubMed ID: 23081995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [
    Lumen D; Vugts D; Chomet M; Imlimthan S; Sarparanta M; Vos R; Schreurs M; Verlaan M; Lang PA; Hippeläinen E; Beaino W; Windhorst AD; Airaksinen AJ
    Bioconjug Chem; 2022 May; 33(5):956-968. PubMed ID: 35442642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.